David Reese

Executive vice president of research and development at Amgen

Executive vice president of research and development at Amgen

David Reese on KCRW

Biotech companies worldwide are scrambling to develop possible treatments for COVID-19.

Amgen researchers are using antibodies to develop COVID-19 treatment

Biotech companies worldwide are scrambling to develop possible treatments for COVID-19.

from Greater LA

More from KCRW

In the first episode of Samaritans, we meet Christine Curtiss, an unhoused woman that KCRW reporter Anna Scott followed for a year.

from Samaritans

Hundreds of librarians are working as contact tracers in LA County during the COVID-19 pandemic.

from Greater LA

Scientific evidence shows that wearing a mask can protect both the wearer and the community around them from COVID-19.

from To the Point

Physicians use micromorts to measure the likelihood of death from an activity. A micromort equates to a one in 1 million chance of dying.

from KCRW Features

In the second episode of Samaritans, Christine comes face-to-face with the life or death consequences of living outdoors.

from Samaritans

Practice guidelines use evidence to help doctors and patients make decisions about care. But, if the guidelines are biased so too are the decisions.

from Second Opinion

Nico is obsessed with counting calories. But this compulsion to monitor food doesn’t line up with how they see themself. Why does Nico want parts of their body to disappear?

from Bodies

Dr. Michael Wilkes says the risk of contracting the virus might rise as restrictions ease, leading to a liability showdown in the workplace between employers and employees.

from KCRW Features

The state is giving the go-ahead for in-person religious services to resume. But attendees must wear face coverings and be screened for fevers.

from KCRW Features